The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) is meeting now to discuss and vote on whether to support recommending the Moderna coronavirus vaccine for adults.
According to an agenda of the meeting, the event is scheduled to run from 10 a.m. to 5 p.m. ET.
The first portion of the meeting focuses on the Moderna vaccine, which was recently approved by the Food and Drug Administration for use in adults. A vote on whether the advisers support recommending the vaccine is scheduled for 1 p.m. ET.
The afternoon includes presentations and discussions around extended intervals for the vaccines, vaccine safety and myocarditis following vaccination.
Following the ACIP vote, CDC Director Dr. Rochelle Walensky would need to sign off on any recommendations.
There’s no difference between the approved vaccine and the vaccine previously available through emergency use authorization.
More on the vaccine: Moderna’s is the second Covid-19 vaccine to receive full approval from the FDA. Pfizer’s Covid-19 vaccine, Comirnaty, was approved for use in people age 16 and older in August. The Pfizer vaccine is also authorized for use in people ages 5 to 15.
The two-dose vaccine has been available in the US under FDA emergency use authorization since Dec. 18, 2020. Since then, more than 204 million doses of Moderna’s Covid-19 vaccine have been administered in the US, accounting for about 38% of all doses administered, according to data from the US Centers for Disease Control and Prevention.
CNN’s Naomi Thomas and Ben Tinker contributed reporting to this post.